BioSpace News Archive

Bio NC

Precision BioSciences Announces Publication in Nature Metabolism Supporting ARCUS® In Vivo Gene Editing as a Potentially Curative Treatment for Mitochondrial Diseases

Precision BioSciences, Inc. today announced publication in the journal Nature Metabolism of a peer reviewed manuscript titled “Efficient elimination of MELAS-associated m.3243G mutant mitochondrial DNA by an engineered mitoARCUS nuclease.”

December 4, 2023
·
11 min read
Business

LSL Pharma Group Appoints Luc Mainville as Chief Financial Officer

LSL PHARMA GROUP INC (TSXV: LSL) (“the Company” or “LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to announce the appointment of Mr. Luc Mainville as Senior Vice President and Chief Financial Officer effective December 4, 2023.

December 4, 2023
·
3 min read
Biotech Bay

Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease

Alterity Therapeutics today announced that promising new data on the effect of ATH434 in a Parkinson’s disease primate model was presented at the Future of Parkinson’s Disease Conference 2023 that took place November 30 – December 3, 2023 in Austin, TX, USA.

December 4, 2023
·
7 min read
SABCS23: Reveal Genomics® Unleashes Groundbreaking DNADX® Liquid Biopsy Data for Metastatic Breast Cancer

REVEAL GENOMICS, S.L., a pioneering biotechnology start-up headquartered in Barcelona committed to advancing cancer care through innovative diagnostic solutions, emphasized the excellent results of DNADX® in data presented at the San Antonio Breast Cancer Symposium 2023 (SABCS23).

December 4, 2023
·
6 min read
Business

Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer

Zenas BioPharma announced the appointment of Jennifer Fox as its Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., Ph. D as Head of Research and Development and Chief Medical Officer.

December 4, 2023
·
4 min read
Genetown

Elicio Therapeutics to Present at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

Elicio Therapeutics, Inc. today announced that Robert Connelly, Chief Executive Officer, will present at the upcoming H.C. Wainwright 4th Annual Precision Oncology Virtual Conference on December 6, 2023 at 10:30 AM ET.

December 4, 2023
·
1 min read
Business

STRATA Skin Science Announces Strengthening of Leadership Team

STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced the promotion of Shmuel Gov to Chief Operating Officer.

December 4, 2023
·
5 min read
BioCapital

Gain Therapeutics to Participate in FORCE Family Office Event with Zacks Small-Cap Research

Gain Therapeutics, Inc. today announced that the Company’s Chief Executive Officer, Matthias Alder, will participate in a fireside chat, hosted by FORCE Family Office, with John Vandermosten, CFA, Senior Analyst for Zacks Small-Cap Research taking place Tuesday, December 5, 2023.

December 4, 2023
·
1 min read
BioMidwest

Standard BioTools and SomaLogic Announce Date for Special Meetings of Stockholders to Vote on Proposed Merger

Standard BioTools Inc. and SomaLogic, Inc. announced that the companies have set a date for their respective Special Meetings of Stockholders in connection with the pending all-stock merger which was previously announced on October 4, 2023.

December 4, 2023
·
11 min read
Business

Cyclerion Appoints Regina Graul, Ph.D., as President

Cyclerion Therapeutics, Inc. today announced that Regina Graul, Ph.D., has joined the company as president, effective immediately.

December 4, 2023
·
5 min read